Division of Cardiology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea.
Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Eur Heart J Cardiovasc Imaging. 2022 Oct 20;23(11):1502-1510. doi: 10.1093/ehjci/jeab180.
This study aimed to assess the impact of valvular/subvalvular calcium burden on procedural and long-term outcomes in patients undergoing transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS).
In this prospective observational cohort study, we included patients with AS undergoing TAVR between March 2010 and December 2019. Calcium burden at baseline was quantified using multidetector computed tomography and the patients were classified into tertile groups according to the amount of calcium. Procedural outcomes [paravalvular leakage (PVL) or permanent pacemaker insertion (PPI)] and 12-month clinical outcomes (composite of death, stroke, or rehospitalization, and all-cause mortality) were assessed. A total of 676 patients (age, 79.8 ± 5.4 years) were analysed. The 30-day rates of moderate or severe PVL (P-for-trend = 0.03) and PPI (P-for-trend = 0.002) proportionally increased with the tertile levels of calcium volume. The 12-month rate of primary composite outcomes was 34.2% in low-tertile, 23.9% in middle-tertile, and 25.8% in high-tertile groups (log-rank P = 0.02). After multivariable adjustment, the risk for primary composite outcomes at 12 months was not significantly different between the tertile groups of calcium volume [reference = low-tertile; middle-tertile, hazard ratio (HR) 0.81; 95% confidence interval (CI) 0.54-1.22; P = 0.31; high-tertile, HR 0.93; 95% CI 0.56-1.57; P = 0.80]. A similar pattern was observed for all-cause mortality.
The rates of PVL and PPI proportionally increased according to the levels of valvular/subvalvular calcium volume, while the adjusted risks for composite outcomes and mortality at 12 months were not significantly different.
本研究旨在评估行经导管主动脉瓣置换术(TAVR)治疗重度主动脉瓣狭窄(AS)患者的瓣下/瓣上钙负荷对手术和长期结局的影响。
在这项前瞻性观察队列研究中,我们纳入了 2010 年 3 月至 2019 年 12 月期间接受 TAVR 的 AS 患者。使用多排螺旋 CT 对基线时的钙负荷进行量化,并根据钙量将患者分为三分位组。评估手术结果[瓣周漏(PVL)或永久性起搏器植入(PPI)]和 12 个月临床结局(死亡、卒中和再住院的复合终点以及全因死亡率)。共分析了 676 例患者(年龄 79.8±5.4 岁)。随着钙容量三分位水平的升高,30 天内中重度 PVL(趋势 P=0.03)和 PPI(趋势 P=0.002)的比例也随之增加。低钙组、中钙组和高钙组的 12 个月主要复合结局发生率分别为 34.2%、23.9%和 25.8%(对数秩 P=0.02)。多变量调整后,12 个月时主要复合结局的风险在钙容量三分位组之间无显著差异[参考值为低钙组;中钙组,风险比(HR)0.81;95%置信区间(CI)0.54-1.22;P=0.31;高钙组,HR 0.93;95%CI 0.56-1.57;P=0.80]。全因死亡率也呈现出类似的模式。
根据瓣下/瓣上钙体积水平,PVL 和 PPI 的发生率呈比例增加,而 12 个月时复合结局和死亡率的调整风险无显著差异。